Even More Features for AWS GovCloud (US)
Hot on the heels of my last GovCloud post, I’ve got even more good news today. Two more AWS services are now available for use in AWS GovCloud (US).
If you are part of the US Federal Government, a US state or local government, if you provide services to them, or if you need to follow Federal regulations on Controlled Unclassified Information (CUI) data protection, you can now make use of the following services:
Amazon Relational Database Service (RDS) – Launch database instances running MySQL, Oracle Database, or Microsoft SQL Server and let RDS take care of all of the common database administration and scaling tasks for you.
Amazon DynamoDB – Use this fully managed NoSQL database to build highly scalable dynamic applications while taking advantage of fast, SSD-based storage and automatic replication across three Availability Zones.
As I mentioned before, we recently added support for High Performance Computing, Elastic Load Balancing, Auto Scaling, CloudWatch Alarms, the Simple Notification Service, the Simple Queue Service, and the ElasticWolf management application.
Putting it all together, you now have access to a very broad and powerful set of services in AWS GovCloud (US). Here are some of the ways that our other AWS customers have been using GovCloud and AWS:
The US Centers for Disease Control and Prevention hosts the BioSense 2.0 application on AWS. Watch this video to learn how they use Amazon S3, Amazon EC2, Elastic MapReduce, and the Amazon Simple Email Service (for push notifications) to build a system that meets their needs for privacy, security, and availability while saving money:
The BioSense application gives local, state, and federal officials the power to monitor and assess a set of symptoms that, taken together, characterize a disease or other threat to public health.
NIH Microbiome Cloud
http://www.ncats.nih.gov was established to speed up the basic scientific discovery for patient therapies and treatments. A new website was created on AWS GovCloud (US) to help catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.